What We Do
From Oncology Learning Network.
Melissa Davis, Ph.D., Weill Cornell Medicine, discusses the ongoing research of genomic sequencing in diverse populations, including disparities and ancestries, presented at the 2021 AACR Annual Meeting.
Using the concepts of Oncologic Anthropology and Ancestry-Aware multi-omic approaches, we investigate tumor types correlated with the social impact of race and the intersection of genetic backgrounds - associated with ancestry.
Our Mission
To ensure that precision medicine, genomic technology and theragnostics are inclusive of multi-ethnic populations, and are utilized toward amelioration of cancer health disparities. We believe that community education and outreach are imperative to fully engage minority populations in research and clinical trials.
“Your work is so important and inspiring.”
— International African Conference Attendee
Landmark publications establishing the functional role of genetic ancestry on tumor biology and types of cancers.
What we have achieved so far…Real Impact.
We have established differential gene regulation on a genome-wide scale between prostate cancer patients (tumor-specific) that also correlate with epigenetic miRNA (genome-wide) data which we have also published recently.
We established the association of specific immune responses; including infiltrating tumor-associated immune cells and circulating chemokine levels in the context of epithelial expression of DARC/ACKR1 in primary tumors.